PersonAuto-indexed · Unverified
Eric Keller
McLean, US· Director, Executive Officer
Named on 6 public capital-raising filings across 2 companies. Compiled automatically from public SEC filings — not verified by this individual.
Companies
Filings (6)
Retension Pharmaceuticals, Inc. raised $12.3M
Retension Pharmaceuticals, Inc.· Director· May 6, 2025
Retension Pharmaceuticals, Inc. raised $12.3M
Retension Pharmaceuticals, Inc.· Executive Officer· May 6, 2025
Response Pharmaceuticals, Inc. raised $3.9M
Response Pharmaceuticals, Inc.· Director· Jun 28, 2024
Response Pharmaceuticals, Inc. raised $3.9M
Response Pharmaceuticals, Inc.· Executive Officer· Jun 28, 2024
Retension Pharmaceuticals, Inc. raised $10.1M
Retension Pharmaceuticals, Inc.· Director· May 15, 2024
Retension Pharmaceuticals, Inc. raised $10.1M
Retension Pharmaceuticals, Inc.· Executive Officer· May 15, 2024